In vivo induction of necrosis in mice fibrosarcoma via intravenous injection of type b staphylococcal enterotoxin.
admin | Related Articles |
In vivo stimulation of modification in mice fibrosarcoma via intravenous shot of identify B staphylococcal enterotoxin.
Biotechnol Lett. 2008 Jul 24;
Authors: Fooladi AA, Sattari M, Hassan ZM, Mahdavi M, Azizi T, Horii A
The bacterial superantigen staphylococcal enterotoxin B (SEB) is a multipotent communicator of cytotoxic T-cell state and cytokine creation in vivo. We investigated the existence of the therapeutic covering of bioarm in patients with fibrosarcoma. The anti-tumor gist of bioarm in mice with inoculated fibrosarcoma (WEHI-164) was examined by intravenous (IV) and intratumoral (IT) shot and the sizes of the inoculated tumors, IFN-gamma production, and CD4+/CD8+ T radiophone filtration were determined. The inoculated tumors were also examined histologically. In the mice in the IV-injected group, a momentous change (P < 0.02) of growth filler was observed in comparability with mice in the IT-injected and curb groups. Furthermore, the mice in the IV-injected assemble showed significantly higher levels of IFN-gamma (P < 0.009) and CD4+/CD8+ T radiophone filtration when compared with the another groups (P < 0.02). A significantly higher oftenness of modification in growth tissues was also observed in mice in the IV-injected assemble (P < 0.05). Our inform findings declare that growth radiophone modification is caused by accumulated cytotoxic T-cell state and cytokine levels in salutation to the IV shot of bioarm and that bioarm haw be a beatific choice for ingest as a new therapy in patients with fibrosarcoma.
PMID: 18651228 [PubMed - as supplied by publisher]
(Source: Biotechnology Letters)
Posted in Cancer |